{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:22:51Z","timestamp":1794352971073,"version":"4.9.0"},"reference-count":30,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"unspecified","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"French Ministry of Health","award":["2009-172"],"award-info":[{"award-number":["2009-172"]}]},{"name":"PHRC","award":["2009-172"],"award-info":[{"award-number":["2009-172"]}]},{"DOI":"10.13039\/501100004726","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Recherche Clinique","award":["2009-172"],"award-info":[{"award-number":["2009-172"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2021,5,1]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Whereas first-line bronchial artery embolisation (BAE) is considered standard of care for the management of severe haemoptysis, it is unknown whether this approach is warranted for non-severe haemoptysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research question<\/jats:title>\n                    <jats:p>To assess the efficacy on bleeding control and the safety of first-line BAE in non-severe haemoptysis of mild abundance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design and methods<\/jats:title>\n                    <jats:p>This multicentre, randomised controlled open-label trial enrolled adult patients without major comorbid condition and having mild haemoptysis (onset &lt;72 hours, 100\u2013200 mL estimated bleeding amount), related to a systemic arterial mechanism. Patients were randomly assigned (1:1) to BAE associated with medical therapy or to medical therapy alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Bleeding recurrence at day 30 after randomisation (primary outcome) occurred in 4 (11.8%) of 34 patients in the BAE strategy and 17 (44.7%) of 38 patients in the medical strategy (difference \u221233%; 95% CI \u221213.8% to \u221252.1%, p=0.002). The 90-day bleeding recurrence-free survival rates were 91.2% (95% CI 75.1% to 97.1%) and 60.2% (95% CI 42.9% to 73.8%), respectively (HR=0.19, 95% CI 0.05 to 0.67, p=0.01). No death occurred during follow-up and no bleeding recurrence needed surgery.<\/jats:p>\n                    <jats:p>Four adverse events (one major with systemic emboli) occurred during hospitalisation, all in the BAE strategy (11.8% vs 0%; difference 11.8%, 95% CI 0.9 to 22.6, p=0.045); all eventually resolved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In non-severe haemoptysis of mild abundance, BAE associated with medical therapy had a superior efficacy for preventing bleeding recurrences at 30 and 90 days, as compared with medical therapy alone. However, it was associated with a higher rate of adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT01278199\">NCT01278199<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2021-000949","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T11:35:57Z","timestamp":1622806557000},"page":"e000949","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance"],"prefix":"10.1136","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct01278199","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Muriel","family":"Fartoukh","sequence":"first","affiliation":[{"name":"Groupe Hospitalier Universitaire APHP-Sorbonne Universit\u00e9, H\u00f4pital Tenon, Service de M\u00e9decine intensive r\u00e9animation, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Demoule","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Universitaire APHP-Sorbonne Universit\u00e9, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Service de M\u00e9decine Intensive et R\u00e9animation (D\u00e9partement R3S), Sorbonne Universit\u00e9, INSERM, UMRS1158 Neurophysiologie Respiratoire Exp\u00e9rimentale et Clinique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Soins Intensifs, HEGP, AP-HP, Innovations Th\u00e9rapeutiques en H\u00e9mostase, INSERM UMRS 1140, Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Tuffet","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Clinical Research Platform of East of Paris (URC-CRC-CRB), H\u00f4pital Saint Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bergot","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Centre Hospitalier Universitaire de Caen, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cendrine","family":"Godet","sequence":"additional","affiliation":[{"name":"CHU Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9998-8578","authenticated-orcid":false,"given":"Claire","family":"Andrejak","sequence":"additional","affiliation":[{"name":"Service de Pneumologie, CHU Amiens-Picardie, UR 4294 AGIR, universit\u00e9 Picardie Jules-Verne, 80054 Amiens, France, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Pontier-Marchandise","sequence":"additional","affiliation":[{"name":"Service de Pneumologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Parrot","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Universitaire APHP-Sorbonne Universit\u00e9, H\u00f4pital Tenon, Service de Pneumologie et Oncologie thoracique, Centre Constitutif Maladies Pulmonaires Rares, APHP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mayaux","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Universitaire APHP-Sorbonne Universit\u00e9, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Service de M\u00e9decine Intensive et R\u00e9animation (D\u00e9partement R3S), APHP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Meyer","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris; Service de Radiologie, HEGP, AP-HP, F-75015 Paris, France, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cluzel","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Universitaire APHP-Sorbonne Universit\u00e9, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Service de Radiologie, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Sapoval","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris; Service de Radiologie, HEGP, AP-HP, F-75015 Paris, France, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Le Pennec","sequence":"additional","affiliation":[{"name":"Service de radiologie diagnostique et th\u00e9rapeutique - CHU Avenue de la Cote de Nacre \u2013 CS 30001 14033 Caen cedex 9, France, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Carette","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Universitaire APHP-Sorbonne Universit\u00e9, H\u00f4pital Tenon, Service de Radiologie, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Cadranel","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Universitaire APHP-Sorbonne Universit\u00e9, H\u00f4pital Tenon, Service de Pneumologie et Oncologie thoracique, Centre Constitutif Maladies Pulmonaires Rares, Sorbonne Universit\u00e9, GRC n\u00b004, Theranoscan, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Rousseau","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Clinical Research Platform of East of Paris (URC-CRC-CRB), H\u00f4pital Saint Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Khalil","sequence":"additional","affiliation":[{"name":"Groupe Hospitalier Universitaire APHP-Sorbonne Universit\u00e9, H\u00f4pital Tenon, Service de Radiologie, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassome","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Clinical Research Platform of East of Paris (URC-CRC-CRB), H\u00f4pital St Antoine, Paris, France, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"2025083110032334000_8.1.e000949.1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00218214"},{"key":"2025083110032334000_8.1.e000949.2","doi-asserted-by":"publisher","DOI":"10.1159\/000331501"},{"key":"2025083110032334000_8.1.e000949.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00102108"},{"key":"2025083110032334000_8.1.e000949.4","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-8-11"},{"key":"2025083110032334000_8.1.e000949.5","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivt383"},{"key":"2025083110032334000_8.1.e000949.6","first-page":"365","article-title":"[Treatment of severe hemoptysis with terlipressin. Study of the efficacy and tolerance of this product]","volume":"6","author":"Ramon","year":"1989","journal-title":"Rev Mal Respir"},{"key":"2025083110032334000_8.1.e000949.7","doi-asserted-by":"publisher","DOI":"10.1159\/000274492"},{"key":"2025083110032334000_8.1.e000949.8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.diii.2015.06.007","article-title":"Severe hemoptysis: from diagnosis to embolization","volume":"96","author":"Khalil","year":"2015","journal-title":"Diagn Interv Imaging"},{"key":"2025083110032334000_8.1.e000949.9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1148\/rg.2018170122","article-title":"An Interventionalist's guide to hemoptysis in cystic fibrosis","volume":"38","author":"Monroe","year":"2018","journal-title":"Radiographics"},{"key":"2025083110032334000_8.1.e000949.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(02)00337-8"},{"key":"2025083110032334000_8.1.e000949.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.06.011"},{"key":"2025083110032334000_8.1.e000949.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2008.11.010"},{"key":"2025083110032334000_8.1.e000949.13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.97.2.469"},{"key":"2025083110032334000_8.1.e000949.14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.5.1431"},{"key":"2025083110032334000_8.1.e000949.15","doi-asserted-by":"publisher","DOI":"10.1148\/122.1.33"},{"key":"2025083110032334000_8.1.e000949.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200609-1362OC"},{"key":"2025083110032334000_8.1.e000949.17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/15412555.2017.1394285","article-title":"Classification of chronic obstructive pulmonary disease (COPD) according to the new global initiative for chronic obstructive lung disease (gold) 2017: comparison with gold 2011","volume":"15","author":"Mar\u00e7\u00f4a","year":"2018","journal-title":"COPD"},{"key":"2025083110032334000_8.1.e000949.18","doi-asserted-by":"publisher","DOI":"10.5152\/dir.2017.16454"},{"key":"2025083110032334000_8.1.e000949.19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.chest.2018.09.026","article-title":"Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial","volume":"154","author":"Wand","year":"2018","journal-title":"Chest"},{"key":"2025083110032334000_8.1.e000949.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-009-1591-3"},{"key":"2025083110032334000_8.1.e000949.21","first-page":"909","article-title":"Risk factors for recurrence of haemoptysis following bronchial artery embolisation for life-threatening haemoptysis","volume":"11","author":"van den Heuvel","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083110032334000_8.1.e000949.22","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00010114"},{"key":"2025083110032334000_8.1.e000949.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01813-2017"},{"key":"2025083110032334000_8.1.e000949.24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00134-002-1553-6","article-title":"Massive hemoptysis requiring intensive care","volume":"29","author":"Ong","year":"2003","journal-title":"Intensive Care Med"},{"key":"2025083110032334000_8.1.e000949.25","doi-asserted-by":"publisher","DOI":"10.1159\/000264921"},{"key":"2025083110032334000_8.1.e000949.26","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00018709"},{"key":"2025083110032334000_8.1.e000949.27","doi-asserted-by":"publisher","DOI":"10.1378\/chest.115.4.996"},{"key":"2025083110032334000_8.1.e000949.28","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.2379"},{"key":"2025083110032334000_8.1.e000949.29","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.4161"},{"key":"2025083110032334000_8.1.e000949.30","doi-asserted-by":"publisher","DOI":"10.1016\/S1051-0443(97)70517-7"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2021-000949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:03:32Z","timestamp":1756659812000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2021-000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6,4]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/bmjresp-2021-000949"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2021-000949","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}